Select 'Apply to REP' under Program-Specific Elements to apply to this rotation.
Elective Description
The Pediatric Oncology Branch (POB) practices a combined modality approach to the treatment of childhood malignancies, with a focus on rare tumors and recurrent leukemia and solid tumors. The POB has active programs in drug development, experimental therapeutics, and immunotherapy. Patients include children, adolescents, and young adults enrolled in current National Institutes of Health (NIH)-sponsored clinical trials. The rotation emphasizes the important connection between research and patient care in pediatric oncology. The Resident will be supervised directly by the POB attending physician and clinical Fellows. Residents will attend daily inpatient and outpatient rounds and multiple weekly POB conferences. Residents are expected to research relevant topics and present a 30-minute talk toward the end of their rotation.
Staff
- Nirali Shah, MD
- Rosandra Kaplan, MD
- Brigitte Widemann, MD
- Corina Gonzalez, MD
- Andrea Gross, MD
- John Glod, MD, PhD
- Mary Frances Wedekind, DO
- David Young, MD, PhD
- Haneen Shalabi, DO
- Srivandana Akshintala, MBBS, MPH
- Lisa McReynolds, MD, PhDv
- Jack Shern, MD
- Paul Meltzer, MD, PhD
- Peter Aplan, MD
- Mari Yohe, MD, PhD
- Christine Heske, MD
- Jason Levine, MD
- Lea Cunningham, MD
- Anandani Nellan, MD
- Anupam Verma, MD
- Rosa Nguyen, MD, PhD
Selection of Applicants
Applicants should indicate their goals for the rotation in their cover letter. Only one Resident will be allowed per session. Availability may be limited due to programmatic constraints.
This is a highly specialized rotation in research Pediatric Oncology. Only residents with experience and/or interest in pediatric oncology will be considered and possibly selected, on a case-by-case basis.
All applicants will be expected to provide COVID-19 vaccination verification.